Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ACTINIUM PHARMACEUTICALS, INC.

(ATNM)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Sector news Bio Therapeutic Drugs
03:49aSANOFI : Regeneron's Second Late-Stage Inflammatory Disease Trial Meets Primary Endpoints
MT
01:38aSANOFI : Regeneron's Dupixent Improves Swallowing in Late-Stage Study
MT
10/22MODERNA : COVID SCIENCE-COVID-19 vaccines not linked to pregnancy loss; mixing vaccines ma..
RE
10/22PFIZER : FDA Panel to Vote on Pfizer COVID-19 Shots for Kids; Data Shows Vaccine 90.7% Eff..
MT
10/22PFIZER : Norway Stops Second Dose COVID-19 Vaccine Inoculations For Minors
MT
10/22PFIZER : BioNTech COVID-19 Vaccine Shows Nearly 91% Efficacy in Kids
MT
10/22BIONTECH : Deutsche Bank Starts BioNTech at Hold with $250 Price Target
MT
10/22PFIZER : BioNTech COVID Vaccine Reportedly Shows Nearly 91% Efficacy in Kids
MT
10/22BB BIOTECH AG : BB Biotech: i ricavi -2-
DJ
10/22PRESS RELEASE : BB Biotech: Gains realized -2-
DJ
10/22SANOFI : Regeneron's Dupixent Meets Primary, Key Secondary Endpoints in Phase 3 Trial in P..
MT
10/22REGENERON, SANOFI : Dupixent Hits Main Endpoints in Prurigo Nodularis Trial
DJ
10/22SANOFI : Regeneron's Dupixent Cuts Itch in Late-Stage Skin Disease Study
MT
10/21BIONTECH : Shares Rise After Data Shows Efficacy of COVID-19 Vaccine's Booster Dose
MT
10/21Canada, Pfizer Strike Deal on Pediatric Vaccine Doses
DJ
10/21European ADRs Move Lower in Thursday Trading
MT
10/21PFIZER : BioNTech Say Phase 3 Trial Data Showed Efficacy of Their COVID-19 Vaccine's Boost..
MT
10/21MODERNA : EU regulator verdict on Moderna COVID-19 booster shot next week
RE
10/21Gilead Sciences, Inc. Presents Long-Term Switch Data Reinforcing Biktarvy as A Treatmen..
CI
10/21PFIZER : BioNTech Report Nearly 96% Efficacy from COVID-19 Vaccine Booster Dose
MT
10/21PRESS RELEASE : Pfizer and BioNTech Announce Phase -4-
DJ
10/21PRESS RELEASE : Pfizer and BioNTech Announce Phase -3-
DJ
10/21PRESS RELEASE : Pfizer and BioNTech Announce Phase -2-
DJ
10/21PRESS RELEASE : Pfizer and BioNTech Announce Phase 3 Trial Data Showing High Efficacy of a..
DJ
10/21PFIZER : BioNTech's COVID-19 Vaccine Provides Strong Protection in Adolescents from Delta ..
MT
10/21PFIZER, BIONTECH : Phase 3 Study Shows High Efficacy of Covid-19 Vaccine Booster
DJ
10/21Novartis Signs New Deal With BioNTech to Support Production of Covid-19 Vaccine
MT
10/21Novartis Expands Fill-and-Finish Deal with BioNTech for COVID-19 Jabs
MT
10/21NOVARTIS : extends deal to make Pfizer/BioNTech vaccines
RE
10/20Novartis in New Agreement With BioNTech to Help Manufacture Covid-19 Vaccine
DJ
10/20SANOFI : Regeneron Win Expanded US FDA Nod for Asthma Drug Dupixent
MT
10/20REGENERON PHARMACEUTICALS : Sanofi Say FDA Has Expanded Approval of Dupixent to Include Ch..
MT
10/20FDA Authorizes Booster Shots for Moderna, J&J Vaccines; Greenlights Mixing Brands
MT
10/20White House Unveils COVID-19 Vaccine Distribution Plan for Children Ages 5 to 11 Upon A..
MT
10/20European ADRs Move Slightly Higher in Wednesday Trading
MT
10/20KAROLINSKA INSTITUTET : Two COVID-19 Vaccine Doses Increase Airway Antibodies After Infect..
MT
10/19PFIZER : CDC Study Finds Pfizer, BioNTech Vaccine 93% Effective Against Severe COVID-19 in..
MT
10/19Atea plunges after COVID-19 treatment fails to help patients in study
RE
10/19European ADRs 0.6% Higher Tuesday Morning
MT
10/19GILEAD SCIENCES : to Donate 103,000 Vials of Veklury to Indonesia, Armenia
MT
10/19Vertex to Present Long-Term Data Demonstrating Significant Benefits of Treatment With C..
CI
10/19FDA May Soon Allow Mix-and-Match COVID-19 Booster Shots
MT
10/18BIONTECH : EMA Issues Positive Opinion For New Formulation Of BioNTech/Pfizer COVID-19 Vac..
MT
10/18VERTEX PHARMACEUTICALS : Reports 'Unprecedented' Results From Trial of VX-880 to Treat Typ..
MT
10/18MOLECULAR TEMPLATES : Vertex Terminates Collaboration
DJ
10/18GILEAD SCIENCES : Secures FDA Approval for Expanded Indication of Biktarvy for Treatment o..
MT
10/18Molecular Templates, Inc. Receives Notice from Vertex Pharmaceuticals Incorporated to T..
CI
10/18Gilead Sciences, Inc. Announces the U.S. FDA Approves a New Low-Dose Tablet Dosage form..
CI
10/18Vertex Pharmaceuticals Incorporated Announces Positive Day 90 Data for the First Patien..
CI
10/18Gilead Says FDA Approves Expanded Indication of Biktarvy for Treatment of HIV-1 in Pedi..
DJ
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on ACTINIUM PHARMACEUTICALS, INC.